Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S.

Oncogene. 2012 Oct 18;31(42):4517-26. doi: 10.1038/onc.2011.631. Epub 2012 Jan 16.

PMID:
22249248
[PubMed - indexed for MEDLINE]
2.

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.

Chen P, Zhao X, Ma L.

Mol Cell Biochem. 2013 Nov;383(1-2):49-58. doi: 10.1007/s11010-013-1753-0. Epub 2013 Jul 11.

PMID:
23842624
[PubMed - indexed for MEDLINE]
3.

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.

BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.

PMID:
23151088
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].

Chen XJ, Wu LM, Xu XB, Feng XW, Xie HY, Zhang M, Shen Y, Wang WL, Liang TB, Zheng SS.

Zhonghua Wai Ke Za Zhi. 2007 Oct 1;45(19):1354-8. Chinese.

PMID:
18241575
[PubMed - indexed for MEDLINE]
5.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
[PubMed - indexed for MEDLINE]
6.

Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.

Xu D, He XX, Chang Y, Sun SZ, Xu CR, Lin JS.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2367-73. doi: 10.5754/hge12458.

PMID:
22773266
[PubMed - indexed for MEDLINE]
7.

Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.

Zeng ZL, Li FJ, Gao F, Sun DS, Yao L.

J Surg Oncol. 2013 Feb;107(2):105-10. doi: 10.1002/jso.23210. Epub 2012 Jul 5.

PMID:
22767438
[PubMed - indexed for MEDLINE]
8.

Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.

Wang XQ, Zhu YQ, Lui KS, Cai Q, Lu P, Poon RT.

Clin Cancer Res. 2008 Nov 1;14(21):6813-20. doi: 10.1158/1078-0432.CCR-08-0626.

PMID:
18980975
[PubMed - indexed for MEDLINE]
Free Article
9.

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X.

Oncogene. 2012 Aug 2;31(31):3607-20. doi: 10.1038/onc.2011.523. Epub 2011 Nov 21.

PMID:
22105365
[PubMed - indexed for MEDLINE]
10.

Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.

Ito T, Sato F, Kan T, Cheng Y, David S, Agarwal R, Paun BC, Jin Z, Olaru AV, Hamilton JP, Selaru FM, Yang J, Matsumura N, Shimizu K, Abraham JM, Shimada Y, Mori Y, Meltzer SJ.

Int J Cancer. 2011 Nov 1;129(9):2134-46. doi: 10.1002/ijc.25874. Epub 2011 Mar 11.

PMID:
21170987
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.

Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, Niida A, Miyano S, Inazawa J.

PLoS One. 2013;8(3):e60155. doi: 10.1371/journal.pone.0060155. Epub 2013 Mar 27.

PMID:
23544130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.

Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.

J Gastroenterol Hepatol. 2013 Mar;28(3):565-75. doi: 10.1111/j.1440-1746.2012.07271.x.

PMID:
22989374
[PubMed - indexed for MEDLINE]
13.

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.

Feng B, Wang R, Chen LB.

Cancer Lett. 2012 Apr 28;317(2):184-91. doi: 10.1016/j.canlet.2011.11.024. Epub 2011 Nov 25.

PMID:
22120675
[PubMed - indexed for MEDLINE]
14.

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.

Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, Savic R, Ward SC, Thung S, Chiang DY, Alsinet C, Tovar V, Roayaie S, Schwartz M, Bruix J, Waxman S, Friedman SL, Golub T, Mazzaferro V, Llovet JM.

Gastroenterology. 2011 May;140(5):1618-28.e16. doi: 10.1053/j.gastro.2011.02.009. Epub 2011 Feb 13.

PMID:
21324318
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.

Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.

J Hepatol. 2012 Sep;57(3):584-91. doi: 10.1016/j.jhep.2012.04.031. Epub 2012 May 18.

PMID:
22613005
[PubMed - indexed for MEDLINE]
16.

Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.

Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO.

J Hepatol. 2011 Jun;54(6):1177-84. doi: 10.1016/j.jhep.2010.09.023. Epub 2010 Oct 31.

PMID:
21145831
[PubMed - indexed for MEDLINE]
17.

microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.

Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.

Int J Oncol. 2012 Mar;40(3):747-56. doi: 10.3892/ijo.2011.1242. Epub 2011 Oct 24.

PMID:
22025269
[PubMed - indexed for MEDLINE]
18.

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.

Mok WC, Wasser S, Tan T, Lim SG.

World J Gastroenterol. 2012 Jul 21;18(27):3527-36. doi: 10.3748/wjg.v18.i27.3527.

PMID:
22826617
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

miR-221 overexpression contributes to liver tumorigenesis.

Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9. doi: 10.1073/pnas.0907904107. Epub 2009 Dec 15.

PMID:
20018759
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma.

Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, Zheng X, Yang G.

PLoS One. 2012;7(4):e35800. doi: 10.1371/journal.pone.0035800. Epub 2012 Apr 20.

PMID:
22536440
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk